Evidence map›Paper›PMID 19953607›Full record

ArticleHuman mutation2010

XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients.

Sikandar G Khan, Koji Yamanegi, Zhi-Ming Zheng, Jennifer Boyle, Kyoko Imoto, Kyu-Seon Oh, Carl C Baker, Engin Gozukara, Ahmet Metin, Kenneth H Kraemer

Open access · greenAbstract read
In one paragraph

Article in Human mutation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Journal of medical genetics · 2022
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.International journal of clinical and experimental pathology · 2014
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Sikandar G KhanDermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA.
Koji Yamanegi
Zhi-Ming Zheng
Jennifer Boyle
Kyoko Imoto
Kyu-Seon Oh
Carl C Baker
Engin Gozukara
Ahmet Metin
Kenneth H Kraemer
Center for Cancer Research · USInonu University · TRNational Cancer Institute · USVan Yüzüncü Yıl Üniversitesi · TR

Funding

DNA Repair in Human Cancer-Prone Genetic DiseasesZIABC004517 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KRAEMER, KENNETH H · 2009 to 2024
$26.5M
Intramural NIH HHS ZIA BC004517
6 · The paper itself

Abstract

Mutations in two branch-point sequences (BPS) in intron 3 of the XPC DNA repair gene affect pre-mRNA splicing in association with xeroderma pigmentosum (XP) with many skin cancers (XP101TMA) or no skin cancer (XP72TMA), respectively. To investigate the mechanism of these abnormalities we now report that transfection of minigenes with these mutations revealed abnormal XPC pre-mRNA splicing that mimicked pre-mRNA splicing in the patients' cells. DNA oligonucleotide-directed RNase H digestion demonstrated that mutations in these BPS disrupt U2 snRNP-BPS interaction. XP101TMA cells had no detectable XPC protein but XP72TMA had 29% of normal levels. A small amount of XPC protein was detected at sites of localized ultraviolet (UV)-damaged DNA in XP72TMA cells which then recruited other nucleotide excision repair (NER) proteins. In contrast, XP101TMA cells had no detectable recruitment of XPC or other NER proteins. Post-UV survival and photoproduct assays revealed greater reduction in DNA repair in XP101TMA cells than in XP72TMA. Thus mutations in XPC BPS resulted in disruption of U2 snRNP-BPS interaction leading to abnormal pre-mRNA splicing and reduced XPC protein. At the cellular level these changes were associated with features of reduced DNA repair including diminished NER protein recruitment, reduced post-UV survival and impaired photoproduct removal.

Indexed as

Base SequenceCell LineCell SurvivalDNADNA-Binding ProteinsDNA DamageDNA RepairExonsGenome, HumanHumansMolecular Sequence DataMutationPhenotypeProtein BindingPyrimidine DimersRibonuclease HDNADNA-Binding ProteinsPyrimidine DimersRibonuclease HRibonucleoprotein, U2 Small NuclearRNA, MessengerRNA PrecursorsXPC protein, human

Identifiers

PMID19953607
PMCPMC2815018
OpenAlexW2034731071

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.